Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects

NCT06920719 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subject

Interventions

DRUG: YHP2406
DRUG: YHR2501

Sponsor

Yuhan Corporation